Acrodermatitis continua of Hallopeau in a patient with myelodysplastic syndrome

British Journal of Dermatology

Volumn 134, Issue 4, 1996, Pages 754-757

  Van Der Kerkhof, P C M ^a   Steijlen, P M ^a   Raymakers, R A P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTARABINE; ETRETIN; IDARUBICIN; INTERLEUKIN 3; METHOTREXATE; METHYLPREDNISOLONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW; CASE REPORT; CLINICAL TRIAL; DERMATITIS; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PUSTULAR PSORIASIS; TOPICAL DRUG ADMINISTRATION;

EID: 0029966071     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1996.90802.x     Document Type: Article

References (36)

1. Camp RDR. Psoriasis. In: Textbook of Dermatology (Champion RH, Burton JL, Ebling FJG, eds). Oxford: Blackwell Scientific Publications, 1992; 1391-457.
2. Cattaneo M, Betti R, Lodi A, Boidi G. Su un caso di acrodermatite continua di Hallopeau trattato con etretinato. G Ital Derm Venereol 1986; 121: 143-5.
3. Pearson LH, Allen BS, Smith JG. Acrodermatitis continua Hallopeau: treatment with etretinate and review of relapsing pustular eruptions of hands and feet. J Am Acad Dermatol 1984; 11: 755-62.
4. Braun-Falco O, Berthold D, Ruzicka T. Psoriasis pustulosa generalisata - Klassification, Klinik und Therapie. Hautarzt 1987; 38: 509-20.
5. Meinardi MMHM, de Rie MA, Bos JD. Oral cyclosporin is effective in clearing persistent pustulosis palmaris et plantaris. Acta Derm Venereol (Stockh) 1990; 70: 77-9.
6. Takigawa M, Miyachi Y, Uehara M et al. Treatment of pustulosis palmaris et plantaris with oral doses of colchicine. Arch Dermatol 1982; 118: 458-60.
7. Thomsen K. Pustulosis palmaris et plantaris treated with methotrexate. Acta Derm Venereol (Stockh) 1971; 51: 397-400.
8. Calkin E, Reznick L, Bauer W. Clinical and metabolic effects of prednisone, prednisolone and cortisone in a patient with acrodermatitis continua Hallopeau. N Engl J Med 1957; 256: 245-50.
9. Dooren-Greebe van RJ, van de Kerkhof PCM, Chang A, Happle R. Acitretin monotherapy in acrodermatitis continua Hallopeau. Acta Derm Venereol (Stockh) 1989; 69: 344-6.
10. Findlay GM, Mackenzie RD. The bone marrow in deficiency diseases. J Pathol 1992; 25: 402-15.
11. Wolback SB, Howe PR. Tissue changes following deprivation of fat soluble A vitamin. J Exp Med 1925; 42: 753-77.
12. Douer D, Koeffler HP. Increase of early erythroid progenitor cells (BFU-E) by retinoic acid in vitro. J Clin Invest 1982; 69: 1039-41.
13. Bailey-Wood R, May S, Jacobs A. The effect of retinoids CFU-GM from normal subjects and patients with myelodysplastic syndrome. Br J Haematol 1985; 59: 15-20.
14. Clark RE, Ismail SAD, Jacobs A et al. A randomized trial of 13-cis retinoic acid with or without cytosine arabinoside in patients with the myelodysplastic syndrome. Br J Haematol 1987; 66: 77-83.
15. Koeffler HP. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood 1983; 62: 709-21.
16. Hast R, Beksac M, Axdorph S et al. Effects of retinoids on in vitro differentiation on bone marrow cells in the myelodysplastic syndrome. Med Oncol Tumor Pharmacother 1986; 3: 35-8.
17. Land H, Parada LF, Weinberg RA. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 1983; 304: 596-607.
18. Dual TF, Huang JS. Roles of growth factor activities in oncogenesis. Blood 1984; 64: 951-8.
19. Sporn MB, Roberts AB. Autocrine growth factors and cancer. Nature 1985; 313: 745-7.
20. Jacobs A. Human preleukemia: do we have a model? Br J Cancer 1987; 55: 105.
21. Breitman TR, Collins SJ, Keene BR. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 1981; 57: 1000-14.
22. Breitman TR, Selonick SE, Collins SE. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci (USA) 1980; 77: 2936-40.
23. Garg LC, Brown JC. Friend erythroleukemia cell differentiation: induction by retinoids. Differentiation 1983; 25: 79-83.
24. Douer D. Retinoids - blood cells and therapy of leukemia. In: Retinoids: New Treatments in Research and Therapy. Retinoid Symposium Geneva 1984 (Saurat JH. ed.). Basel: Karger. 1985: 375-83.
25. Douer D, Koeffler HP. Retinoic acid enhances colony stimulating factor-induced clonal growth of normal human myeloid progenitor cells in vitro. Exp Cell Res 1982; 138: 193-201.
26. Degos L, Chromienne C, Daniel MT et al. Treatment of first relapse of acute promyelocytic leukemia using all-trans-retinoic acid: a model for differentiation therapy. Lancet 1990; ii: 1440-1.
27. Flynn PJ, Miller WJ, Weisdorf DJ et al. Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations. Blood 1983; 63: 1211-17.
28. Nilsson B. Probable in vivo induction of differentiation by retinoic acid of promyelocytes in acute promyelocytic leukemia. Br J Haematol 1984; 57: 365-71.
29. Meng-re H, Yu-Chen Y, Shu-rong C et al. Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567-72.
30. Castaigne S, Chomienne C, Ballerini P et al. All-trans retinoic acid: a novel differentiation therapy for acute promyelocytic leukemia. Blood 1989; 74 (Suppl. 1): 117a.
31. Sampi K, Honma Y, Hozumi M, Sahura M. Discrepancy between in vitro and in vivo inductions of differentiation by retinoids of human acute promyelocytic cells in relapse. Leuk Res 1985; 9: 1475.
32. Chomienne C, Balitrand N, Abita JP. Inefficacy of the synthetic aromatic retinoid etretinate and of its free acid on the in vitro differentiation of leukemic cells. Leuk Res 1986; 10: 1079-81
33. Ladoux A, Cragoe EJ, Geny B et al. Differentiation of human promyelocytic HL-60 cells by retinoic acid is accompanied by an increase in the intracellular pH. The role of the Na/H exchange system. J Biol Chem 1987; 262: 811-16.
34. Izumi T, Hatake K, Imagawa S et al. Leukemia (APL) with myeloblastama in the oral cavity developing after receiving all-trans acid (ATRA). Rinsko Katsueki 1994; 35: 598-602.
35. Lawrence HJ, Conner K, Kelly MA et al. Cis-retinoic acid stimulates the clonal growth of some myeloid leukemia cells in vitro. Blood 1987; 69: 302-7.
36. Garewal HS, List A, Meijskens F et al. Phase II trial of fenretinide [N-(4-hydroxyphenyl) retinoide] in myelodysplasia: possible retinoid induced disease acceleration. Leukemia Res 1989; 13: 339.